Literature DB >> 11128538

Anemia, splenomegaly, and increased osmotic fragility of erythrocytes in Abyssinian and Somali cats.

B Kohn1, M H Goldschmidt, A E Hohenhaus, U Giger.   

Abstract

OBJECTIVE: To determine clinical and clinicopathologic features of a chronic intermittent severe hemolytic anemia characterized by erythrocyte osmotic fragility in Abyssinian and Somali cats.
DESIGN: Case series. ANIMALS: 13 Abyssinian and 5 Somali cats. PROCEDURES: History, pedigree information, and results of routine laboratory tests, special erythrocyte studies, and histologic evaluation of splenic and hepatic specimens were analyzed.
RESULTS: Age at which clinical signs of anemia were first apparent ranged from 6 months to 5 years. Ten cats had splenomegaly. Most often, the PCV was between 15 and 25%, but it was as low as 5% at some times. The anemia was characterized by macrocytosis and mild to moderate reticulocytosis, but no poikilocytosis. Hyperglobulinemia, lymphocytosis, mild hyperbilirubinemia, and high hepatic enzyme activities were common findings. Results of Coombs tests and tests for infectious diseases were negative. The erythrocytic osmotic fragility was high in affected cats (mean osmotic fragility, 0.66 to 0.78%), compared with healthy cats (0.48 to 0.58). No specific membrane protein abnormality, erythrocyte enzyme deficiency, or hemoglobinopathy was identified. Histologic evaluation of splenic and hepatic specimens revealed extramedullary hematopoiesis and hemosiderosis. Four of the 5 Somali cats were closely related. CONCLUSIONS AND CLINICAL RELEVANCE: On the basis of results of pedigree analyses, the apparent breed predilection, and the exclusion of other known causes of anemia in cats, we believe that the hemolytic anemia in these cats was likely a result of a novel hereditary erythrocyte defect. A genetic predisposition to immune-mediated destruction of erythrocytes could not be ruled out.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11128538     DOI: 10.2460/javma.2000.217.1483

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  8 in total

1.  Erythrocytic pyruvate kinase mutations causing hemolytic anemia, osteosclerosis, and seconday hemochromatosis in dogs.

Authors:  G Inal Gultekin; K Raj; P Foureman; S Lehman; K Manhart; O Abdulmalik; U Giger
Journal:  J Vet Intern Med       Date:  2012 Jul-Aug       Impact factor: 3.333

2.  Bilirubin Encephalopathy in a Domestic Shorthair Cat With Increased Osmotic Fragility and Cholangiohepatitis.

Authors:  E T Contreras; U Giger; J L Malmberg; J M Quimby; P A Schaffer
Journal:  Vet Pathol       Date:  2015-09-09       Impact factor: 2.221

3.  Increased erythrocytic osmotic fragility in anemic domestic shorthair and purebred cats.

Authors:  Claudia Tritschler; Keijiro Mizukami; Karthik Raj; Urs Giger
Journal:  J Feline Med Surg       Date:  2015-05-28       Impact factor: 2.015

4.  Erythrocytic pyruvate kinase deficiency and AB blood types in Australian Abyssinian and Somali cats.

Authors:  V R Barrs; U Giger; B Wilson; C T T Chan; A E Lingard; L Tran; A Seng; P J Canfield; J A Beatty
Journal:  Aust Vet J       Date:  2009 Jan-Feb       Impact factor: 1.281

5.  Bilirubin cholelithiasis and haemosiderosis in an anaemic pyruvate kinase-deficient Somali cat.

Authors:  C van Geffen; K Savary-Bataille; K Chiers; U Giger; S Daminet
Journal:  J Small Anim Pract       Date:  2008-08-05       Impact factor: 1.522

6.  Erythrocyte pyruvate kinase deficiency mutation identified in multiple breeds of domestic cats.

Authors:  Robert A Grahn; Jennifer C Grahn; Maria Ct Penedo; Chris R Helps; Leslie A Lyons
Journal:  BMC Vet Res       Date:  2012-10-30       Impact factor: 2.741

7.  Comparison of 4 direct Coombs' test methods with polyclonal antiglobulins in anemic and nonanemic dogs for in-clinic or laboratory use.

Authors:  L L Caviezel; K Raj; U Giger
Journal:  J Vet Intern Med       Date:  2014-01-16       Impact factor: 3.333

8.  In vitro assessment of quality of citrate-phosphate-dextrose-adenine-1 preserved feline blood collected by a commercial closed system.

Authors:  Chiara Crestani; Annalisa Stefani; Antonio Carminato; Angelica Cro; Katia Capello; Michela Corrò; Elisa Bozzato; Franco Mutinelli; Marta Vascellari
Journal:  J Vet Intern Med       Date:  2018-04-10       Impact factor: 3.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.